CD22L Conjugation to Insulin Attenuates Insulin-Specific B Cell Activation.

Apley, Kyle D; Griffith, Amber S; Downes, Grant M; Ross, Patrick; Farrell, Mark P; Kendall, Peggy; Berkland, Cory J

Apley, Kyle D; Griffith, Amber S; Downes, Grant M; Ross, Patrick; Farrell, Mark P; Kendall, Peggy; Berkland, Cory J.

Afiliação

Apley KD; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047, United States.
Griffith AS; Department of Medicine, Division of Allergy and Immunology, Washington University School of Medicine, St. Louis, Missouri 63110, United States.
Downes GM; Bioengineering Graduate Program, University of Kansas, Lawrence, Kansas 66045, United States.
Ross P; Department of Medicinal Chemistry, University of Kansas, Lawrence, Kansas 66047, United States.
Farrell MP; Department of Medicinal Chemistry, University of Kansas, Lawrence, Kansas 66047, United States.
Kendall P; Department of Medicine, Division of Allergy and Immunology, Washington University School of Medicine, St. Louis, Missouri 63110, United States.
Berkland CJ; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047, United States.

Bioconjug Chem ; 34(11): 2077-2088, 2023 11 15.

Article em En | MEDLINE | ID: mdl-37883211

Assuntos

Diabetes Mellitus Tipo 1; Insulina; Camundongos; Animais; Humanos; Diabetes Mellitus Tipo 1/tratamento farmacológico; Linfócitos B; Ativação Linfocitária; Linfócitos T; Camundongos Transgênicos; Antígenos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Insulina Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google